Modulation of E2F activity in primary mouse B cells following stimulation via surface IgM and CD40 receptors

European Journal of Immunology

Volumn 29, Issue 10, 1999, Pages 3380-3389

  Lam, Eric W F ^a   Glassford, Janet ^a   Van Der Sman, Jeroen ^a   Banerji, Lolita ^a   Pizzey, Arnold R ^b   Thomas, N Shaun B ^b   Klaus, Gerry G B ^c  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

B lymphocyte; CD40; E2F; IgM; Pocket protein

Indexed keywords

CD40 ANTIGEN; IMMUNOGLOBULIN M; IMMUNOGLOBULIN RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; TRANSCRIPTION FACTOR E2F;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; DEPHOSPHORYLATION; ELECTROPHORETIC MOBILITY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION;

EID: 0032845820     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199910)29:10<3380::AID-IMMU3380>3.0.CO;2-C     Document Type: Article

References (42)

1. Banchereau, J., Bazan, F., Blanchard, D., Briere, F., Galizzi, J. P., van Kooten, C., Liu, Y. J., Rousset, F. and Saeland, S., The CD40 antigen and its ligand. Annu. Rev. Immunol. 1994. 12: 881-922.
2. Wheeler, K., Pound, J. D., Gordon, J. and Jefferis, R., Engagement of CD40 lowers the threshold for activation of resting B cells via antigen receptor. Eur. J. Immunol. 1993. 23: 1165-1168.
3. Roy, M., Waldschmidt, T., Aruffo, A., Ledbetter, J. A. and Noelle, R. J., The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J. Immunol. 1993 151: 2497-2510.
4. Poudrier, J. and Owens, T., Co-stimulation by anti-immunoglobulin is required for B cell activation by CD40Llow T cells. Eur. J. Immunol. 1994. 24: 2993-2999.
5. Johnson-Leger, C., Christenson, J. R., Holman, M. and Klaus, G. G., Evidence for a critical role for IL-2 in CD40-mediated activation of naive B cells by primary CD4 T cells. J. Immunol. 1998. 161: 4618-4626.
6. Nevins, J. R., Transcriptional regulation. A closer look at E2F [news]. Nature 1992. 358: 375-376.
7. Lam, E.W.-F. and La Thangue, N. B., DP and E2F proteins: coordinating transcription with cell cycle progression. Curr. Opin. Cell Biol. 1994. 6: 859-866.
8. Sardet, C., LeCam, L. E., Fabbrizio, E. and Vidal, M., E2Fs and the retinoblastoma protein family. In Ghysdael, J. and Yaniv, M. (Eds) Oncogenes as Transcriptional Regulators. Birkhäuser Verlag, Berlin, Germany 1997, pp 1-63.
9. Dyson, N., The regulation of E2F by pRB-family proteins. Genes Dev. 1998. 12: 2245-2262.
10. Sherr, C. J., Cancer cell cycles. Science 1996. 274: 1672-1677.
11. Sears, R., Ohtani, K. and Nevins, J. R., Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals. Mol. Cell. Biol. 1997. 17: 5227-5235.
12. Leone, G., DeGregori, J., Yan, Z., Jakoi, L., Ishida, S., Williams, R. S. and Nevins, J. R., E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev. 1998. 12: 2120-2130.
13. Weinberg, R. A., The retinoblastoma protein and cell cycle control. Cell 1995. 81: 323-330.
14. Cartwright, P., Muller, H., Wagener, C., Holm, K. and Helin, K., E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription. Oncogene 1998. 17: 611-623.
15. Morkel, M., Wenkel, J., Bannister, A. J., Kouzarides, T. and Hagemeier, C., An E2F-like repressor of transcription [letter]. Nature 1997. 390: 567-568.
16. Trimarchi, J. M., Fairchild, B., Verona, R., Moberg, A., Andon, N. and Lees, J. A., E2F-6, a member of the E2F family that can behave as a transcriptional repressor. Proc. Natl. Acad. Sci. USA 1998. 95: 2850-2855.
17. Schwarz, J. K., Devoto, S. H., Smith, E. J., Chellappan, S. P., Jakoi, L. and Nevins, J. R., Interactions of the p107 and Rb proteins with E2F during the cell proliferation response. EMBO J. 1993. 12: 1013-1020.
18. Beijersbergen, R. L, Carlee, L., Kerkhoven, R. M. and Bernards, R., Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Dev. 1995. 9: 1340-1353.
19. Mayol, X., Garriga, J. and Grana, X., Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130. Oncogene 1995. 11: 801-808.
20. Johnson, D. G., Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity. Oncogene 1995. 11: 1685-1692.
21. Krek, W., Xu, G. and Livingston, D. M., Cyclin A-kinase rgulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell 1995. 83: 1149-1158.
22. Solvason, N., Wu, W. W., Kabra, N., Wu, X., Lees, E. and Howard, M. C., Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes. J. Exp. Med. 1996. 184: 407-417.
23. Tanguay, D. A. and Chiles, T. C., Cell cycle-specific induction of Cdk2 expression in B lymphocytes following antigen receptor cross-linking. Mol. Immunol. 1994. 31: 634-649.
24. Tanguay, D. A. and Chiles, T. C., Regulation of the catalytic subunit (p34PSK-J3/cdk4) for the major D-type cyclin in mature B lymphocytes. J. Immunol. 1996. 156: 539-548.
25. Tanguay, D. A., Colarusso, T. P., Pavlovic, S., Irigoyen, M., Howard, R. G., Bartek, J., Chiles, T. C. and Rothstein, T. L., Early induction of cyclin D2 expression in phorbol ester-responsive B-1 lymphocytes. J. Exp. Med. 1999. 189: 1685-1690.
26. Reid, S. and Snow, E. C., The regulated expression of cell cycle-related proteins as B-lymphocytes enter and progress through the G1 cell cycle stage following delivery of complete versus partial activation stimuli. Mol. Immunol. 1996. 33: 1139-1151.
27. Blanchard, D. A., Affredou, M. T. and Vazquez, A., Modulation of the p27kip1 cyclin-dependent kinase inhibitor expression during IL-4-mediated human B cell activation. J. Immunol. 1997. 158: 3054-3061.
28. Darzynkiewicz, Z., Crissman, H., Traganos, F. and Steinkamp, J., Cell heterogeneity during the cell cycle. J. Cell. Physiol. 1982. 113: 465-474.
29. van der Sman, J., Thomas, N. S. and Lam, E.W.-F., Modulation of E2F complexes during G0 to S phase transition in human primary B-lymphocytes. J. Biol. Chem. 1999. 274: 12009-12016.
30. Lam, E.W.-F., Choi, M. S., van der Sman, J., Burbidge, S. A. and Klaus, G. G., Modulation of E2F activity via signaling through surface IgM and CD40 receptors in WEHI-231 B lymphoma cells. J. Biol. Chem. 1998. 273: 10051-10057.
31. Moberg, K., Starz, M. A. and Lees, J. A., E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol. Cell. Biol. 1996. 16: 1436-1449.
32. Mulligan, G. J., Wong, J. and Jacks, T., p130 is dispensable in peripheral T lymphocytes: evidence for functional compensation by p107 and pRB. Mol. Cell. Biol. 1998. 18: 206-220.
33. Mudryj, M., Devoto, S. H., Hiebert, S. W., Hunter, T., Pines, J. and Nevins, J. R., Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A. Cell 1991. 65: 1243-1253.
34. Williams, C. D., Linch, D. C., Sorensen, T. S., La Thangue, N. B. and Thomas, N. S., The predominant E2F complex in human primary haemopoietic cells and in AML blasts contains E2F-4, DP-1 and p130. Br. J. Haematol. 1997. 96: 688-696.
35. Vairo, G., Livingston, D. M. and Ginsberg, D., Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev. 1995. 9: 869-881.
36. Shan, B., Zhu, X., Chen, P. L., Durfee, T., Yang, Y., Sharp, D. and Lee, W. H., Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F. Mol. Cell. Biol. 1992. 12: 5620-5631.
37. Zhu, L., Zhu, L., Xie, E. and Chang, L. S., Differential roles of two tandem E2F sites in repression of the human p107 promoter by retinoblastoma and p107 proteins. Mol. Cell. Biol. 1995. 15: 3552-3562.
38. Hasbold, J., Johnson-Leger, C., Atkins, C. J., Clark, E. A. and Klaus, G. G., Properties of mouse CD40: cellular distribution of CD40 and B cell activation by monoclonal anti-mouse CD40 antibodies. Eur. J. Immunol. 1994. 24: 1835-1842.
39. Williams, C. D., Linch, D. C., Watts, M. J. and Thomas, N. S., Characterization of cell cycle status and E2F complexes in mobilized CD34+ cells before and after cytokine stimulation. Blood 1997. 90: 194-203.
40. Bandara, L. R., Lam, E. W.-F., Sorensen, T. S., Zamanian, M., Girling, R. and La Thangue, N. B., DP-1: a cell cycle-regulated and phosphorylated component of transcription factor DRTF1/E2F which is functionally important for recognition by pRb and the adenovirus E4 orf 6/7 protein. EMBO J. 1994. 13: 3104-3114.
41. Lam, E. W.-F. and Watson, R. J., An E2F-binding site mediates cell cycle regulated repression of mouse B-myb transcription. EMBO J. 1993. 12: 2705-2713.
42. Belbrahem, A., Godden-Kent, D. and Mittnacht, S., Regulation and activity of the retinoblastoma protein family in growth factor-deprived and TGF(beta)-treated keratinocytes. Exp. Cell Res. 1996 225: 286-293.